SunderMudaliarMD

Endocrinology • San Diego, CA

Diabetes, Lipid Metabolism

Clinical Professor of Medicine, University of California, San Diego; Director Special Diagnostic and Treatment Unit, VA Medical Center, San Diego

Join to view full profile

Dr. Mudaliar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mudaliar's full profile

Already have an account?

Office
3350 La Jolla Village Dr # 111g
San Diego, CA 92161
Phone+1 858-642-3152

Fax+1 858-642-6242

Education & Training

University of California (San Diego) Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1994 - 1996
Rochester Regional Health/Unity Hospital (Rochester)Residency, Internal Medicine, 1992 - 1994
Stanley Medical College SMCClass of 1977, MBBS

Certifications & Licensure

CA State Medical License 1993 - 2025

Awards, Honors, & Recognition

Fellow (FACE) American Association of Clinical Endocrinology

Clinical Trials

Pilot Study Assessing Insulin Pump Therapy in Type 2 Diabetes Start of enrollment: 2008 Feb 01
Completed
Not Applicable
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
Completed
Phase 3

Publications & Presentations

PubMed

697 citations
Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease.
Sunder Mudaliar, Robert R. Henry, Arun J. Sanyal, Linda Morrow, Hanns-Ulrich Marschall
Gastroenterology. 2013-09-01
2 citations
Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study).
Jennifer B Green, Brendan M Everett, Alokananda Ghosh, Alokananda Ghosh, Alokananda Ghosh
Circulation. 2024-03-26
79 citations
Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell and Mononuclear Cell Transplantation in Type 2 Diabetes Mellitus: A Randomized, Placebo-Controlled Com...
Shobhit Bhansali, Pinaki Dutta, Vinod Kumar, Mukesh K Yadav, Ashish Jain
Stem Cells and Development. 2017-04-01

Journal Articles

Effect of Canagliflozin Treatment on Hepatic Triglyceride Content and Glucose Metabolism in Patients with Type 2 Diabetes
Diana Barb, Sunder Mudaliar, Kenneth Cusi, Diabetes, Obesity and Metabolism

Lectures

Reversing Gluco-Lipotoxicity
Sunder Mudaliar, MD - 6/13/2014

Grant Support

Actos NOW For The Prevention Of DiabetesNational Center For Research Resources2006